Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' WATSON WP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 74 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Cottrell, L; Golding, BT; Munter, T; Watson, WP
      In vitro metabolism of chloroprene: Species differences, epoxide stereochemistry and a de-chlorination pathway

      CHEMICAL RESEARCH IN TOXICOLOGY
    2. Holt, JDS; Watson, WP; Little, HJ
      Studies on a model of long term alcohol drinking

      BEHAVIOURAL BRAIN RESEARCH
    3. Veizovic, T; Beech, JS; Stroemer, RP; Watson, WP; Hodges, H
      Resolution of stroke deficits following contralateral grafts of conditionally immortal neuroepithelial stem cells

      STROKE
    4. Clark, A; Lindgren, S; Brooks, SP; Watson, WP; Little, HJ
      Chronic infusion of nicotine can increase operant self-administration of alcohol

      NEUROPHARMACOLOGY
    5. Watson, WP; Cottrell, L; Zhang, DP; Golding, BT
      Metabolism and molecular toxicology of isoprene

      CHEMICO-BIOLOGICAL INTERACTIONS
    6. Boogaard, PJ; van Sittert, NJ; Watson, WP; de Kloe, KP
      A novel DNA adduct, originating from 1,2-epoxy-3,4-butanediol, is the major DNA adduct after exposure to [2,3-C-14]-1,3-butadiene, but not after exposure to [4-C-14]-1,2-epoxy-3-butene

      CHEMICO-BIOLOGICAL INTERACTIONS
    7. Xing, JZ; Carnelley, T; Lee, J; Watson, WP; Booth, E; Weinfeld, M; Le, XC
      Assay for DNA damage using immunochemical recognition and capillary electrophoresis

      CAPILLARY ELECTROPHORESIS OF NUCLEIC ACIDS, VOL I: INTRODUCTION TO THE CAPILLARY ELECTROPHORESIS OF NUCLEIC ACIDS
    8. Zhang, DP; Bleasdale, C; Golding, BT; Watson, WP
      Synthesis of enantiopure isoprene epoxides from (S)-lactic acid via 'dispoke' intermediates

      CHEMICAL COMMUNICATIONS
    9. Boogaard, PJ; de Kloe, KP; Wong, BA; Sumner, SCJ; Watson, WP; van Sittert, NJ
      Quantification of DNA adducts formed in liver, lungs, and isolated lung cells of rats and mice exposed to C-14-styrene by nose-only inhalation

      TOXICOLOGICAL SCIENCES
    10. van Sittert, NJ; Megens, HJJJ; Watson, WP; Boogaard, PJ
      Biomarkers of exposure to 1,3-butadiene as a basis for cancer risk assessment

      TOXICOLOGICAL SCIENCES
    11. Little, HJ; Clark, A; Watson, WP
      Investigations into pharmacological antagonism of general anaesthesia

      BRITISH JOURNAL OF PHARMACOLOGY
    12. Richardson, KA; Peters, MMCG; Wong, BA; Megens, RHJJJ; van Elburg, PA; Booth, ED; Boogaard, PJ; Bond, JA; Medinsky, MA; Watson, WP; van Sittert, NJ
      Quantitative and qualitative differences in the metabolism of C-14-1,3-butadiene in rats and mice: Relevance to cancer susceptibility

      TOXICOLOGICAL SCIENCES
    13. Smith, JW; Watson, WP; Stephens, DN; Little, HJ
      The calcium channel antagonist, nimodipine, decreases operant self-administration of low concentrations of ethanol

      BEHAVIOURAL PHARMACOLOGY
    14. Watson, WP; Little, HJ
      Correlation between increases in dihydropyridine binding in vivo and behavioural signs of ethanol withdrawal in mice

      ALCOHOL AND ALCOHOLISM
    15. Booth, ED; Loose, RW; Watson, WP
      Effects of solvent on DNA adduct formation in skin and lung of CD1 mice exposed cutaneously to benzo(a)pyrene

      ARCHIVES OF TOXICOLOGY
    16. Potter, D; Booth, ED; Brandt, HCA; Loose, RW; Priston, RAJ; Wright, AS; Watson, WP
      Studies on the dermal and systemic bioavailability of polycyclic aromatic compounds in high viscosity oil products

      ARCHIVES OF TOXICOLOGY
    17. Brandt, HCA; Booth, ED; de Groot, PC; Watson, WP
      Development of a carcinogenic potency index for dermal exposure to viscousoil products

      ARCHIVES OF TOXICOLOGY
    18. Boogaard, PJ; van Elburg, PA; de Kloe, KP; Watson, WP; van Sittert, NJ
      Metabolic inactivation of 2-oxiranylmethyl 2-ethyl-2,5-dimethylhexanoate (C(10)GE) in skin, lung and liver of human, rat and mouse

      XENOBIOTICA
    19. Watson, WP; Little, HJ
      Prolonged effects of chronic ethanol treatment on responses to repeated nicotine administration: interactions with environmental cues

      NEUROPHARMACOLOGY
    20. Little, HJ; Butterworth, AR; O'Callaghan, MJ; Wilson, J; Cole, J; Watson, WP
      Low alcohol preference among the "high alcohol preference" C57 strain of mice; preference increased by saline injections

      PSYCHOPHARMACOLOGY
    21. Richardson, KA; Peters, MMCG; Megens, RHJJJ; van Elburg, PA; Golding, BT; Boogaard, PJ; Watson, WP; van Sittert, NJ
      Identification of novel metabolites of butadiene monoepoxide in rats and mice

      CHEMICAL RESEARCH IN TOXICOLOGY
    22. Watson, WP; Homewood, N; Little, HJ
      Differing acute interactions of ethanol with two structurally related dihydropyridines, nitrendipine and felodipine

      BRAIN RESEARCH BULLETIN
    23. BOOTH ED; BRANDT HCA; LOOSE RW; WATSON WP
      CORRELATION OF P-32 POSTLABELING-DETECTION OF DNA-ADDUCTS IN MOUSE SKIN IN-VIVO WITH THE POLYCYCLIC AROMATIC COMPOUND CONTENT AND MUTAGENICITY IN SALMONELLA-TYPHIMURIUM OF A RANGE OF OIL PRODUCTS

      Archives of toxicology
    24. WATSON WP
      RANDERATH,ERIKA PHD (1934-1997) - OBITUARY

      Mutagenesis
    25. RANDERATH K; SRIRAM P; MOORTHY B; ASTON JP; BAAN RA; VANDENBERG PTM; BOOTH ED; WATSON WP
      COMPARISON OF IMMUNOAFFINITY CHROMATOGRAPHY ENRICHMENT AND NUCLEASE P1 PROCEDURES FOR P-32 POSTLABELING ANALYSIS OF PAH-DNA ADDUCTS

      Chemico-biological interactions
    26. WATSON WP; LITTLE HJ
      EFFECT OF PRIOR CHRONIC ETHANOL INTAKE ON THE LOCOMOTOR RESPONSE TO AN ENVIRONMENT ASSOCIATED WITH REPEATED NICOTINE ADMINISTRATION

      British Journal of Pharmacology
    27. BAILEY CP; MANLEY SJ; WATSON WP; WONNACOTT S; MOLLEMAN A; LITTLE HJ
      CHRONIC ETHANOL ADMINISTRATION ALTERS ACTIVITY IN VENTRAL TEGMENTAL AREA NEURONS AFTER CESSATION OF WITHDRAWAL HYPEREXCITABILITY

      Brain research
    28. WILSON J; WATSON WP; LITTLE HJ
      CCKB ANTAGONISTS PROTECT AGAINST ANXIETY-RELATED BEHAVIOR PRODUCED BYETHANOL WITHDRAWAL, MEASURED USING THE ELEVATED PLUS-MAZE

      Psychopharmacology
    29. WATSON WP; LITTLE JJ
      EFFECTS OF DIHYDROPYRIDINES ON THE COMPONENTS OF THE ETHANOL WITHDRAWAL SYNDROME - POSSIBLE EVIDENCE FOR INVOLVEMENT OF POTASSIUM, AS WELL AS CALCIUM

      Alcoholism, clinical and experimental research
    30. SMALL RD; GOLDING BT; WATSON WP
      SPECIES-DIFFERENCES IN THE STEREOCHEMISTRY OF THE METABOLISM OF ISOPRENE IN-VITRO

      Xenobiotica
    31. GOLDING BT; BLEASDALE C; MCGINNIS J; MULLER S; REES HT; REES NH; FARMER PB; WATSON WP
      THE MECHANISM OF DECOMPOSITION OF N-METHYL-N-NITROSOUREA (MNU) IN WATER AND A STUDY OF ITS REACTIONS WITH 2'-DEOXYGUANOSINE, 2'-DEOXYGUANOSINE 5'-MONOPHOSPHATE AND D(GTGCAC)

      Tetrahedron
    32. WATSON WP; ROBINSON E; LITTLE HJ
      THE NOVEL ANTICONVULSANT, GABAPENTIN, PROTECTS AGAINST BOTH CONVULSANT AND ANXIOGENIC ASPECTS OF THE ETHANOL WITHDRAWAL SYNDROME

      Neuropharmacology
    33. SMITH JW; WATSON WP; STEPHENS DN; LITTLE HJ
      EFFECT OF THE CALCIUM-CHANNEL ANTAGONIST, NIMODIPINE, IN DECREASING RESPONDING FOR THE ORAL SELF-ADMINISTRATION OF LOW CONCENTRATIONS OF ETHANOL

      British Journal of Pharmacology
    34. WATSON WP; LITTLE HJ
      INCREASED STIMULANT EFFECTS OF AMPHETAMINE AND COCAINE ARE SEEN 7 DAYS AFTER CESSATION OF CHRONIC BARBITAL TREATMENT IN MICE

      British Journal of Pharmacology
    35. WATSON WP; CLARK AM; OCALLAGHAN MJ; LITTLE HJ
      EFFECTS OF CORTICOSTERONE TREATMENT ON THE ETHANOL PREFERENCE OF THE LACG (ALCOHOL-AVOIDING) STRAIN OF MICE

      British Journal of Pharmacology
    36. WILSON J; WATSON WP; BUTTERWORTH AR; LITTLE HJ
      THE ETHANOL PREFERENCE OF LOW DRINKERS OF THE C57 STRAIN IS INCREASEDBY SALINE INJECTIONS - CHANGE PREVENTED BY A CCKB ANTAGONIST

      British Journal of Pharmacology
    37. GOLDING BT; SLAICH PK; KENNEDY G; BLEASDALE C; WATSON WP
      MECHANISMS OF FORMATION OF ADDUCTS FROM REACTIONS OF GLYCIDALDEHYDE WITH 2'-DEOXYGUANOSINE AND OR GUANOSINE/

      Chemical research in toxicology
    38. BLEASDALE C; SMALL RD; WATSON WP; WILSON J; GOLDING BT
      STUDIES ON THE MOLECULAR TOXICOLOGY OF BUTA-1,3-DIENE AND ISOPRENE EPOXIDES

      Toxicology
    39. RIDINGS JE; BARRATT MD; CARY R; EARNSHAW CG; EGGINGTON CE; ELLIS MK; JUDSON PN; LANGOWSKI JJ; MARCHANT CA; PAYNE MP; WATSON WP; YIH TD
      COMPUTER-PREDICTION OF POSSIBLE TOXIC ACTION FROM CHEMICAL-STRUCTURE - AN UPDATE ON THE DEREK SYSTEM

      Toxicology
    40. BLEASDALE C; KENNEDY G; MACGREGOR JO; NIESCHALK J; PEARCE K; WATSON WP; GOLDING BT
      CHEMISTRY OF MUCONALDEHYDES OF POSSIBLE RELEVANCE TO THE TOXICOLOGY OF BENZENE

      Environmental health perspectives
    41. KENNEDY G; SLAICH PK; GOLDING BT; WATSON WP
      STRUCTURE AND MECHANISM OF FORMATION OF A NEW ADDUCT FROM FORMALDEHYDE AND GUANOSINE

      Chemico-biological interactions
    42. WATSON WP; MALONE N; LITTLE HJ
      PROLONGED ETHANOL INTAKE ALTERS THE EFFECTS OF REPEATED ADMINISTRATION OF NICOTINE ON LOCOMOTOR-ACTIVITY

      British Journal of Pharmacology
    43. WATSON WP; BUTTERWORTH AR; LITTLE HJ
      INVESTIGATIONS INTO THE EXISTENCE OF MICE OF THE C57 STRAIN WITH A LOW PREFERENCE FOR ETHANOL, AND THE MODIFICATION OF SUCH PREFERENCE

      British Journal of Pharmacology
    44. WATSON WP; COLE JC; RIPLEY TL; LITTLE HJ
      ACAMPROSATE HAS ACTIONS IN THE MURINE ELEVATED PLUS-MAZE

      British Journal of Pharmacology
    45. WILSON J; WATSON WP; LITTLE HJ
      A CCKB ANTAGONIST REDUCES SIGNS OF ANXIETY-RELATED BEHAVIOR IN THE ELEVATED PLUS-MAZE DURING WITHDRAWAL FROM CHRONIC ETHANOL TREATMENT

      British Journal of Pharmacology
    46. WATSON WP; VANSITTERT NJ
      MOLECULAR APPROACHES TO ASSESS CANCER RISKS

      Process safety and environmental protection
    47. DOLL R; ROBERTS LEJ; COX R; STATHER JW; WARNER F; ADAMS GE; ROTBLAT J; CRUMPTON MJ; ARRAND JE; FIELDER R; FINNEY DJ; COGGON D; MCQUAID J; LEWINS JD; SUCKLING CW; ILLING HP; CHADWICK KH; LEENHOUTS HP; HRUDEY SE; LOVELL D; EDWARDS JH; WATSON WP; VANSITTERT NJ; HARBISON S; RENWICK AG; WOODS HF; KING N; BUTLER PJG; GILLIAT BS; CLAYTON DB; RIMINGTON JD
      EXTRAPOLATION OF DOSE-RESPONSE DATA FOR RISK ASSESSMENT - DISCUSSION

      Process safety and environmental protection
    48. BROOKS TM; PRISTON RAJ; WRIGHT AS; WATSON WP
      EVALUATION OF MODIFIED BACTERIAL MUTAGENICITY ASSAYS FOR THE GENOTOXICITY TESTING OF MINERAL-OILS

      Mutagenesis
    49. RANDERATH E; WATSON WP; ZHOU GD; CHANG J; RANDERATH K
      INTENSIFICATION AND DEPLETION OF SPECIFIC BULKY RENAL DNA-ADDUCTS (I-COMPOUNDS) FOLLOWING EXPOSURE OF MALE F344 RATS TO THE RENAL CARCINOGEN FERRIC NITRILOTRIACETATE (FE-NTA)

      Mutation research. Genetic toxicology testing
    50. WATSON WP; LITTLE HJ
      IDENTIFICATION OF DISTINCT COMPONENTS, WITH DIFFERENT TIME COURSES, OF THE CHANGES IN RESPONSE TO CONVULSIVE STIMULI DURING ETHANOL WITHDRAWAL

      The Journal of pharmacology and experimental therapeutics
    51. WATSON WP; ROBINSON E; LITTLE HJ
      GABAPENTIN REDUCES SIGNS OF ANXIETY-RELATED BEHAVIOR MEASURED ON THE ELEVATED PLUS-MAZE DURING WITHDRAWAL FROM CHRONIC ETHANOL TREATMENT

      British Journal of Pharmacology
    52. WATSON WP; CLARK A; LITTLE HJ
      POTENTIATION OF PROPOFOL AND PENTOBARBITAL-ANESTHESIA BY CONVULSANT DRUGS

      British Journal of Pharmacology
    53. WATSON WP; LITTLE HJ
      EFFECTS OF GABAPENTIN ON ETHANOL WITHDRAWAL SIGNS IN MICE

      British Journal of Pharmacology
    54. WATSON WP; DAVIES J; LITTLE HJ
      ACTIONS OF BICUCULLINE AND 4-AMINOPYRIDINE ON GENERAL-ANESTHESIA INDUCED BY ETHANOL OR KETAMINE

      British Journal of Pharmacology
    55. POTTER D; CLARIUS TM; WRIGHT AS; WATSON WP
      MOLECULAR DOSIMETRY OF DNA-ADDUCTS IN RAINBOW-TROUT (ONCORHYNCHUS-MYKISS) EXPOSED TO BENZO(A)PYRENE BY DIFFERENT ROUTES

      Archives of toxicology
    56. BLEASDALE C; ELLWOOD SB; GOLDING BT; SLAICH PK; TAYLOR OJ; WATSON WP
      SYNTHESIS OF [N-15]GUANOSINES AND DEOXY[N-15]GUANOSINES FROM NO-1-(BETA-D-RIBOFURANOSYL)IMIDAZOLE-4-CARBOXAMIDE (AICA-RIBOSIDE)

      Journal of the Chemical Society. Perkin transactions. I
    57. BOOTH ED; ASTON JP; VANDENBERG PTM; BAAN RA; RIDDICK DA; WADE LT; WRIGHT AS; WATSON WP
      CLASS-SPECIFIC IMMUNOADSORPTION PURIFICATION FOR POLYCYCLIC AROMATIC HYDROCARBON-DNA ADDUCTS

      Carcinogenesis
    58. GIBSON NJ; PARKINSON JA; BARLOW T; WATSON WP; BROWN T
      THE STABILITY OF DUPLEX DNA CONTAINING 3,N-4-ETHENO-2'-DEOXYCYTIDINE (EPSILON-DC) - A UV MELTING AND HIGH-RESOLUTION H-1-NMR STUDY

      Journal of the Chemical Society, Chemical Communications
    59. WATSON WP; BLEASDALE C; GOLDING BT
      CHEMICALS AND CANCER - ESTIMATING THE RISK

      Chemistry in Britain
    60. WATSON WP
      VITAMIN-C DOSE - NOT SO MEGA

      Chemistry in Britain
    61. WATSON WP; BLEASDALE C; GOLDING BT
      CHEMICALS AND CANCER - ESTIMATING THE RISK (VOL 30, PG 661, 1994)

      Chemistry in Britain
    62. WATSON WP; MISRA A; CROSS AJ; GREEN AR; LITTLE HJ
      THE DIFFERENTIAL-EFFECTS OF FELODIPINE AND NITRENDIPINE ON CEREBRAL DIHYDROPYRIDINE BINDING EX-VIVO AND THE ETHANOL WITHDRAWAL SYNDROME IN MICE

      British Journal of Pharmacology
    63. WATSON WP; LITTLE HJ
      IDENTIFICATION OF DISTINCT COMPONENTS, WITH DIFFERENT TIME COURSES, OF CONVULSION THRESHOLD CHANGES DURING ETHANOL WITHDRAWAL

      British Journal of Pharmacology
    64. WATSON WP; LITTLE HJ
      THE ACTIONS OF THE PUTATIVE ENDOGENOUS CALCIUM-CHANNEL LIGAND, PALMITOYL CARNITINE, WITH ACUTELY ADMINISTERED ETHANOL AND IN THE ETHANOL WITHDRAWAL SYNDROME

      British Journal of Pharmacology
    65. WATSON WP; LITTLE HJ
      THE EFFECT OF 2 DIHYDROPYRIDINE CALCIUM-CHANNEL ANTAGONISTS ON THE DISTINCTIVE CONVULSIVE COMPONENTS OF ETHANOL WITHDRAWAL

      British Journal of Pharmacology
    66. MCAULEYHECHT KE; LEONARD GA; GIBSON NJ; THOMSON JB; WATSON WP; HUNTER WN; BROWN T
      CRYSTAL-STRUCTURE OF A DNA DUPLEX CONTAINING 8-HYDROXYDEOXYGUANINE-ADENINE BASE-PAIRS

      Biochemistry
    67. LEONARD GA; MCAULEYHECHT KE; GIBSON NJ; BROWN T; WATSON WP; HUNTER WN
      GUANINE-1,N-6-ETHENOADENINE BASE-PAIRS IN THE CRYSTAL-STRUCTURE OF D(CGCGAATT(EPSILON-DA)GCG)

      Biochemistry
    68. WATSON WP; LITTLE HJ
      EFFECTS OF DILTIAZEM IN CONVULSIVE STATES DIFFER FROM THOSE PREVIOUSLY REPORTED FOR DIHYDROPYRIDINE CALCIUM-CHANNEL ANTAGONISTS

      Psychopharmacology
    69. WATSON WP; LITTLE HJ
      INTERACTIONS BETWEEN DILTIAZEM AND ETHANOL - DIFFERENCES FROM THOSE SEEN WITH DIHYDROPYRIDINE CALCIUM-CHANNEL ANTAGONISTS

      Psychopharmacology
    70. BLEASDALE C; GOLDING BT; KENNEDY G; MACGREGOR JO; WATSON WP
      REACTIONS OF MUCONALDEHYDE ISOMERS WITH NUCLEOPHILES INCLUDING TRI-O-ACETYLGUANOSINE - FORMATION OF 1,2-DISUBSTITUTED PYRROLES FROM REACTIONS OF THE (Z,Z)-ISOMER WITH PRIMARY AMINES

      Chemical research in toxicology
    71. WATSON WP; LITTLE HJ
      DILTIAZEM DISPLAYS A BIPHASIC EFFECT ON IN-VIVO BINDING OF [H-3] NITRENDIPINE

      British Journal of Pharmacology
    72. WATSON WP; LITTLE HJ
      THE INCREASE IN IN-VIVO [H-3] NITRENDIPINE BINDING DURING ETHANOL WITHDRAWAL CORRELATES WITH RATINGS OF HANDLING-INDUCED CONVULSIVE BEHAVIOR

      British Journal of Pharmacology
    73. WATSON WP; LITTLE HJ
      DISPARITY BETWEEN TOLERANCE TO THE SEDATIVE EFFECTS OF NITRENDIPINE AND IN-VIVO BINDING OF NITRENDIPINE, FOLLOWING CHRONIC DILTIAZEM TREATMENT

      British Journal of Pharmacology
    74. WATSON WP; HOMEWOOD N; LITTLE HJ
      DIFFERENCE IN ACUTE INTERACTION WITH ETHANOL OF 2 STRUCTURALLY RELATED DIHYDROPYRIDINES - NITRENDIPINE AND FELODIPINE

      British Journal of Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/08/20 alle ore 15:14:00